Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
remibrutinib versus teriflunomide in relapsing multiple sclerosis remodel 1 and remodel 2 two randomised phase 3 trials
Original title: “Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.”
functional stratification of ywhaz variants explains distinct neurodevelopmental disorders
Original title: “Functional stratification of YWHAZ variants explains distinct neurodevelopmental disorders.”